| Open Document File Size: 917,51 KBShare Result on Facebook
City Pordenone / Dublin / Siena / Melanoma Xenografts / Houston / Paris / / Company 3Astex Pharmaceuticals Inc. / / Country United States / Italy / / Event FDA Phase / / Facility University Hospital of Siena / Anderson Cancer Center / / MedicalCondition cancers / tumor / melanoma / cancer / leukemias / decitabine-treated human melanoma / neuroblastoma / / Organization FDA / Department of Oncology / International Congress / 4MD Anderson Cancer Center / University Hospital of Siena / / Person Ann Intern Med / / Product SGI-110 SQ injection / SC / Dacogen / SGI-110-01 / / ProvinceOrState California / / Technology antibodies / /
SocialTag |
11th International Congress on Targeted Anticancer Therapies Paris, March 4-6, 2013 IMMUNOMODULATORY ACTIVITY OF SGI-110, A SECOND GENERATION HYPOMETHYLATING